What is the proper method to reconstitute and dilute clindamycin phosphate for intravenous infusion and intramuscular injection?

Dilution of Clindamycin Phosphate for Injection

Clindamycin phosphate should be diluted in 5% dextrose injection, 0.9% sodium chloride injection, or Lactated Ringer's injection to concentrations of 6-18 mg/mL (equivalent to clindamycin base) for intravenous infusion, while intramuscular injection can be given undiluted directly from the vial. 1

Intravenous Administration

Dilution Concentrations and Solutions

For IV infusion, clindamycin phosphate demonstrates excellent stability across multiple diluent options:

• Acceptable diluents: 5% dextrose injection, 0.9% sodium chloride injection, or Lactated Ringer's injection 1
• Concentration range: 6-18 mg/mL (equivalent to clindamycin base) 1
• Container options: Glass bottles or Mini-Bag containers 1

Stability After Dilution

The diluted solutions maintain both physical and chemical stability under various storage conditions 1:

• Room temperature (25°C): At least 16 days for concentrations of 6,9,12, and 18 mg/mL 1
• Refrigeration (4°C): At least 32 days for concentrations of 6,9, and 12 mg/mL 1
• Frozen (-10°C): At least 8 weeks for concentrations of 6,9, and 12 mg/mL (thaw at room temperature; do not refreeze) 1

Critical caveat: Despite this chemical stability data, good professional practice dictates that compounded admixtures should be administered as soon after preparation as feasible 1.

Premixed Solutions

Premixed CLEOCIN PHOSPHATE IV Solution is available in GALAXY plastic containers at concentrations of 300 mg, 600 mg, and 900 mg in 5% dextrose 1. These require no further dilution and are ready for direct IV administration after checking for leaks and particulate matter 1.

ADD-Vantage System

For the ADD-Vantage system 1:

• 300 mg and 600 mg: Reconstitute in 50 mL of 5% dextrose or 0.9% sodium chloride
• 900 mg: Reconstitute in 100 mL of 5% dextrose or 0.9% sodium chloride

Intramuscular Administration

For IM injection, clindamycin phosphate can be administered undiluted directly from the vial 1. Each mL of the sterile solution contains the equivalent of 150 mg clindamycin 1. Peak concentrations are reached within 3 hours in adults and 1 hour in pediatric patients after IM injection 1.

Compatibility Considerations

Compatible Drug Combinations

When mixing clindamycin with other antibiotics in small-volume admixtures, compatibility has been demonstrated with 2, 3, 4:

• Cefotaxime sodium (stable for 24 hours at room temperature)
• Netilmicin sulfate (stable for 24 hours)
• Cefoxitin sodium, cefamandole nafate, or cefazolin sodium (stable for 48 hours)
• Aztreonam (stable for 48 hours at room temperature, 7 days refrigerated)
• Gentamicin sulfate and amikacin sulfate (stable for 48 hours)

Incompatible Combinations

Critical warning: Tobramycin and clindamycin form a lasting precipitate upon initial contact when admixed together and should never be combined 5.

Pharmacy Bulk Package Handling

For pharmacy bulk packages 1:

• Use only in a pharmacy admixture service under a laminar flow hood
• Enter vial with a small diameter sterile transfer set
• After entry, use entire contents promptly
• Discard any unused portion within 24 hours after initial entry
• Multiple entries with needle and syringe are not recommended

Administration Precautions

• Always inspect solutions visually for particulate matter and discoloration before administration 1
• Do not use unless solution is clear and seal is intact 1
• Do not add supplementary medication to premixed solutions 1
• Never use plastic containers in series connections due to risk of air embolism 1